Peripheral neuropathy encompasses disorders of the peripheral nervous system, affecting the axon and/or the myelin sheath. The prevalence of peripheral neuropathy increases with age. Thought to be of about 3000 per 100 000 in adults generally, this figure could be as high as 8000 above the age of 60 years. However more than half of these cases would be due to impaired glucose metabolism in its various forms. In the remainder, an aetiology may be found in about 70% of cases. The elderly population is at higher risk of peripheral neuropathy, as there is a correlation between age and impairment of the peripheral nervous system. The natural aging process affects adversely the function of peripheral nerves and of their target organs, resulting in the development of motor, sensory and autonomic symptoms in the absence of additional damage of other causes. In addition, the increased prevalence of chronic systemic disorders causing neuropathy, as well as the use of neurotoxic drugs in older patients, contribute to the onset of neuropathy.